Ann: Change of Director's Interest Notice, page-51

Absolutely nothing new whatsoever with your comparison story, in fact, Iron-Oxide Nanoparticle (SPION)
technology has been around for many many years.

What makes us different:
IBX's non- invasive detection for more specific and sensitive detection for cancer (currently specific for HER2
positive primary tumours) is very different and IBX has successfully completed the Pre-clinical Research and
successfully completed the Proof-of-principle that was verified in pre-clinical models, therefore, a long way
down the road when compared to your story.

I won't even start on the other IBX achievements such as 'Ethics approval' or the 'Designated by the FDA as
a Breakthrough Device' or the 'Collaboration with Siemens that will provide multi-modal imaging assessment
of MRI and proprietary relaxometry'. A long way down the road for us as far as other competitors go.
Oh, forgot to mention the current 'First In-human trial' too.

Nothing better to do I guess, so as a non-holder you provide the forum here with stories of others also experimenting
with Iron-Oxide Nanoparticles (SPIONs) for medical use when the use of the tech is nothing new in the medical field.